Silva, L.; Egea, J.; Villanueva, L.; Ruiz, M.; Llopiz, D.; Repáraz, D.; Aparicio, B.; Lasarte-Cia, A.; Lasarte, J.J.; Ruiz de Galarreta, M.;
et al. Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma. Cancers 2020, 12, 3397.
https://doi.org/10.3390/cancers12113397
AMA Style
Silva L, Egea J, Villanueva L, Ruiz M, Llopiz D, Repáraz D, Aparicio B, Lasarte-Cia A, Lasarte JJ, Ruiz de Galarreta M,
et al. Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma. Cancers. 2020; 12(11):3397.
https://doi.org/10.3390/cancers12113397
Chicago/Turabian Style
Silva, Leyre, Josune Egea, Lorea Villanueva, Marta Ruiz, Diana Llopiz, David Repáraz, Belén Aparicio, Aritz Lasarte-Cia, Juan José Lasarte, Marina Ruiz de Galarreta,
and et al. 2020. "Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma" Cancers 12, no. 11: 3397.
https://doi.org/10.3390/cancers12113397
APA Style
Silva, L., Egea, J., Villanueva, L., Ruiz, M., Llopiz, D., Repáraz, D., Aparicio, B., Lasarte-Cia, A., Lasarte, J. J., Ruiz de Galarreta, M., Lujambio, A., Sangro, B., & Sarobe, P.
(2020). Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma. Cancers, 12(11), 3397.
https://doi.org/10.3390/cancers12113397